Invitae Corporation [NVTA] stock Downgrade by Goldman analyst, price target now $2

Invitae Corporation [NYSE: NVTA] traded at a low on 03/20/23, posting a -7.63 loss after which it closed the day’ session at $1.21. The company report on March 16, 2023 that Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for Oncology.

– Expert in the field of gastrointestinal cancer and precision oncology to lead Invitae’s medical oncology team with a particular focus on somatic testing development –.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


– Invitae reports inducement grant under NYSE Rule 303A.08 –.

The results of the trading session contributed to over 11720747 shares changing hands. Over the past one week, the price volatility of Invitae Corporation stands at 9.69% while the volatility over the past one month is 10.10%.

The market cap for NVTA stock reached $316.17 million, with 244.04 million shares outstanding and 240.49 million shares in the current float. Compared to the average trading volume of 8.89M shares, NVTA reached a trading volume of 11720747 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Invitae Corporation [NVTA]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NVTA shares is $2.26 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NVTA stock is a recommendation set at 3.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for Invitae Corporation shares, keeping their opinion on the stock as Sell, with their previous recommendation back on January 31, 2023. While these analysts kept the previous recommendation, Credit Suisse raised their target price to Underperform. The new note on the price target was released on August 25, 2022, representing the official price target for Invitae Corporation stock. On July 26, 2022, analysts decreased their price target for NVTA shares from 8 to 2.50.

The Average True Range (ATR) for Invitae Corporation is set at 0.18, with the Price to Sales ratio for NVTA stock in the period of the last 12 months amounting to 0.61. The Price to Book ratio for the last quarter was 2.88, with the Price to Cash per share for the same quarter was set at 2.09.

How has NVTA stock performed recently?

Invitae Corporation [NVTA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.79. With this latest performance, NVTA shares dropped by -45.00% in over the last four-week period, additionally sinking by -61.95% over the last 6 months – not to mention a drop of -85.08% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NVTA stock in for the last two-week period is set at 27.83, with the RSI for the last a single of trading hit 22.08, and the three-weeks RSI is set at 32.28 for Invitae Corporation [NVTA]. The present Moving Average for the last 50 days of trading for this stock 2.1012, while it was recorded at 1.3500 for the last single week of trading, and 2.5573 for the last 200 days.

Invitae Corporation [NVTA]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Invitae Corporation [NVTA] shares currently have an operating margin of -136.48 and a Gross Margin at +19.23. Invitae Corporation’s Net Margin is presently recorded at -601.64.

Return on Equity for this stock declined to -201.69, with Return on Assets sitting at -90.38.

Invitae Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.10 and a Current Ratio set at 6.40.

Earnings analysis for Invitae Corporation [NVTA]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NVTA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Invitae Corporation go to 8.00%.

Insider trade positions for Invitae Corporation [NVTA]

There are presently around $220 million, or 72.90% of NVTA stock, in the hands of institutional investors. The top three institutional holders of NVTA stocks are: ARK INVESTMENT MANAGEMENT LLC with ownership of 27,072,844, which is approximately -11.144% of the company’s market cap and around 1.00% of the total institutional ownership; VANGUARD GROUP INC, holding 22,587,955 shares of the stock with an approximate value of $27.33 million in NVTA stocks shares; and BLACKROCK INC., currently with $26.34 million in NVTA stock with ownership of nearly 2.536% of the company’s market capitalization.

Positions in Invitae Corporation stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 130 institutional holders increased their position in Invitae Corporation [NYSE:NVTA] by around 18,163,701 shares. Additionally, 132 investors decreased positions by around 25,400,776 shares, while 62 investors held positions by with 138,280,514 shares. The mentioned changes placed institutional holdings at 181,844,991 shares, according to the latest SEC report filing. NVTA stock had 41 new institutional investments in for a total of 2,846,760 shares, while 41 institutional investors sold positions of 7,874,226 shares during the same period.


Please enter your comment!
Please enter your name here